Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients

OBJECTIVE: Although the prognosis of natalizumab-associated progressive multifocal leukoencephalopathy (PML) seems to be better than HIV-associated PML, little is known about the long-term functional outcome in multiple sclerosis (MS) patients and the subsequent return of MS disease activity. We eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Dahlhaus, Stefanie, Hoepner, Robert, Chan, Andrew, Kleiter, Ingo, Adams, Ortwin, Lukas, Carsten, Hellwig, Kerstin, Gold, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Multiple Sclerosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786662/
https://www.ncbi.nlm.nih.gov/pubmed/23606731
http://dx.doi.org/10.1136/jnnp-2013-304897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3786662/
https://www.ncbi.nlm.nih.gov/pubmed/23606731
http://dx.doi.org/10.1136/jnnp-2013-304897

Ejemplares similares